| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1987PNAS...84.3014S |
| P356 | DOI | 10.1073/PNAS.84.9.3014 |
| P932 | PMC publication ID | 304791 |
| P698 | PubMed publication ID | 3554251 |
| P5875 | ResearchGate publication ID | 19608175 |
| P2093 | author name string | Chang SP | |
| Hui GS | |||
| Kramer KJ | |||
| Siddiqui WA | |||
| Kan SC | |||
| Case SE | |||
| Tam LQ | |||
| Yamaga KM | |||
| Chan EB | |||
| P2860 | cites work | Monoclonal Antibody Characterization of Plasmodium Falciparum Antigens | Q57089532 |
| Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites | Q69881920 | ||
| Proteins responsible for a punctate fluorescence pattern in Plasmodium falciparum merozoites | Q70400310 | ||
| Isolation of a Plasmodium falciparum rhoptry protein | Q27972685 | ||
| Human malaria parasites in continuous culture | Q28131626 | ||
| Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys | Q34628596 | ||
| Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene | Q35042128 | ||
| Variation in the gene encoding a major merozoite surface antigen of the human malaria parasite Plasmodium falciparum | Q36097561 | ||
| Freeze-fracture study on the erythrocyte membrane during malarial parasite invasion | Q36205385 | ||
| Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. | Q36347118 | ||
| Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum | Q36348872 | ||
| Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages | Q36349409 | ||
| Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum | Q36349756 | ||
| Localization of the ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum in merozoites and ring-infected erythrocytes | Q36350517 | ||
| Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoites | Q36489015 | ||
| Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite | Q39600996 | ||
| Vaccination of Experimental Monkeys Against Plasmodium falciparum : A Possible Safe Adjuvant | Q39620684 | ||
| Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. | Q40171693 | ||
| Structural diversity of the major surface antigen of Plasmodium falciparum merozoites | Q40669598 | ||
| An Effective Immunization of Experimental Monkeys Against a Human Malaria Parasite, Plasmodium falciparum | Q41276058 | ||
| Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level | Q41434381 | ||
| Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites | Q41971716 | ||
| The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. | Q42937100 | ||
| Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors. | Q44597815 | ||
| Antigenic diversity and size diversity of P. falciparum antigens in isolates from Gambian patients. II. the schizont surface glycoprotein of molecular weight approximately 200 000. | Q46862152 | ||
| A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies | Q46949677 | ||
| Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria | Q47605432 | ||
| Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum | Q47606736 | ||
| Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum | Q47887195 | ||
| Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites | Q47902824 | ||
| Localization of the major Plasmodium falciparum glycoprotein on the surface of mature intraerythrocytic trophozoites and schizonts | Q47979487 | ||
| Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences | Q47979862 | ||
| Use of a synthetic adjuvant in an effective vaccination of monkeys against malaria | Q47990609 | ||
| Immunization against blood-stage rodent malaria using purified parasite antigens | Q47996405 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| merozoite | Q2296434 | ||
| Plasmodium falciparum | Q311383 | ||
| P304 | page(s) | 3014-3018 | |
| P577 | publication date | 1987-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria | |
| P478 | volume | 84 |
| Q47899404 | A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti |
| Q40872637 | A conserved region of the MSP-1 surface protein of Plasmodium falciparum contains a recognition sequence for erythrocyte spectrin |
| Q33756139 | A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites |
| Q47888235 | A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum |
| Q34420625 | A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid system |
| Q43868711 | A novel Plasmodium falciparum erythrocyte binding protein-2 (EBP2/BAEBL) involved in erythrocyte receptor binding |
| Q38952180 | A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses |
| Q34520456 | A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. |
| Q33858336 | A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. |
| Q33599911 | A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. |
| Q35463512 | A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. |
| Q46186627 | A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys |
| Q36352078 | A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. |
| Q38890556 | Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. |
| Q35546112 | Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria |
| Q36354328 | Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages |
| Q38635546 | An update on candidate malaria vaccines |
| Q34334187 | Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum |
| Q57083209 | Analysis of human t cell response to twoplasmodium falciparum merozoite surface antigens |
| Q48006728 | Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates |
| Q37452080 | Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys |
| Q36800846 | Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India |
| Q47852201 | Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax |
| Q48035058 | Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development |
| Q48036521 | Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. |
| Q46227346 | Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria |
| Q35513386 | Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains |
| Q33752297 | Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria |
| Q35456892 | Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies |
| Q35496873 | CD4+ T-helper lymphocyte responses against Babesia bigemina rhoptry-associated protein I. |
| Q41201670 | Cell invasion by the vertebrate stages of Plasmodium |
| Q35773738 | Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic. |
| Q27974365 | Characterization of PfRhop148, a novel rhoptry protein of Plasmodium falciparum |
| Q39517301 | Characterization of allelic variation in the Babesia bovis merozoite surface antigen 1 (MSA-1) locus and identification of a cross-reactive inhibition-sensitive MSA-1 epitope |
| Q34004267 | Characterization of conserved T- and B-cell epitopes in plasmodium falciparum major merozoite surface protein 1 |
| Q35551944 | Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds |
| Q31903366 | Characterization of variable immunodominant antigens of Cowdria ruminantium by ELISA and immunoblots. |
| Q39062961 | Comparison of analytical methods for the evaluation of antibody responses against epitopes of polymorphic protein antigens |
| Q35551948 | Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii |
| Q40374219 | Conservation of antigen components from two recombinant hybrid proteins protective against malaria. |
| Q48378786 | Conserved regions of the Plasmodium yoelii rhoptry protein RhopH3 revealed by comparison with the P. falciparum homologue |
| Q34120959 | Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production |
| Q35550770 | CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine |
| Q36722082 | Cross-reacting epitopes shared between Plasmodium falciparum and its host: the origin of autoreactive antibodies? |
| Q33975652 | Current status of malaria and potential for control |
| Q41264979 | DNA vaccines against malaria: immunogenicity and protection in a rodent model |
| Q41028358 | Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria |
| Q34189990 | Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates |
| Q44438134 | Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine |
| Q40160301 | Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum. |
| Q40715913 | Developments with anti-malarial vaccines. |
| Q33400318 | Distinct roles of Plasmodium rhomboid 1 in parasite development and malaria pathogenesis |
| Q36499325 | Diversity and evolution of the rhoph1/clag multigene family of Plasmodium falciparum |
| Q37239807 | Effect of GPI anchor moiety on the immunogenicity of DNA plasmids encoding the 19-kDa C-terminal portion of Plasmodium falciparum MSP-1. |
| Q40147908 | Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites |
| Q42615032 | Eimeria acervulina: Cloning of a cDNA encoding an immunogenic region of several related merozoite surface and rhoptry proteins |
| Q68566610 | Evidence for surface-coat localisation of a monoclonal antibody-isolated merozoite antigen of Babesia divergens |
| Q41738501 | Expression of hybrid malaria antigens in insect cells and their engineering for correct folding and secretion |
| Q47924321 | Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice. |
| Q34298109 | Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum |
| Q47871262 | Genetic studies on a major merozoite surface antigen of the malaria parasite of rodents, Plasmodium chabaudi |
| Q60044485 | Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka |
| Q40150215 | Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived |
| Q39433256 | Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant |
| Q36998985 | Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies |
| Q36901632 | Identification of Plasmodium falciparum RhopH3 protein peptides that specifically bind to erythrocytes and inhibit merozoite invasion. |
| Q48002650 | Identifying polymorphic regions of the p190 protein from different Plasmodium falciparum strains by using specific T cells |
| Q34842236 | Immunity to asexual blood stage malaria and vaccine approaches |
| Q47905693 | Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli |
| Q33598899 | Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins |
| Q89559305 | Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial |
| Q34003987 | Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. |
| Q48021487 | Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants |
| Q33605280 | Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus |
| Q39655089 | In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system |
| Q35504908 | Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection |
| Q24804056 | Inter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolates |
| Q30714235 | Interaction between two domains of the P. yoelii MSP-1 protein detected using the yeast two-hybrid system |
| Q48055998 | Interallelic recombination in the merozoite surface protein 1 (MSP-1) gene of Plasmodium vivax from Thai isolates |
| Q33550482 | Isolation and serological characterization of a Plasmodium vivax recombinant antigen. |
| Q39228943 | Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population |
| Q41090784 | Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates |
| Q37657392 | Malaria vaccine |
| Q36641624 | Malaria vaccine development |
| Q40847091 | Malaria vaccine: roadblocks and possible solutions |
| Q47843224 | Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation |
| Q35079845 | Measuring immune selection. |
| Q38674929 | Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal |
| Q35549892 | Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria |
| Q40055186 | Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria |
| Q47843233 | Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies |
| Q35519418 | NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria |
| Q35076906 | Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon |
| Q40734085 | Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. |
| Q34541366 | Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro |
| Q47889065 | New World monkey efficacy trials for malaria vaccine development: critical path or detour? |
| Q36302325 | Opinion: antibody-based therapies for malaria |
| Q41955368 | Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19). |
| Q38890670 | Plasmodium falciparum: Genetic stability of the Uganda Palo Alto strain propagated in the squirrel monkey (Saimiri sciureus) |
| Q46281594 | Plasmodium falciparum: Hetero-oligomeric complexes of rhoptry polypeptides |
| Q43871088 | Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. |
| Q49350513 | Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice |
| Q38684677 | Positive selection on the Plasmodium falciparum clag2 gene encoding a component of the erythrocyte-binding rhoptry protein complex |
| Q33282524 | Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum |
| Q34280935 | Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity |
| Q40148558 | Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection |
| Q33356029 | Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses |
| Q40146914 | Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins |
| Q33757015 | Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines |
| Q28345224 | Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region |
| Q38159714 | Protective immunity against malaria after vaccination |
| Q33596771 | Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity. |
| Q36404193 | Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies |
| Q34855814 | Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria |
| Q34006980 | Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro |
| Q36943106 | Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum |
| Q21144326 | Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults |
| Q36218589 | Secretion of Plasmodium falciparum rhoptry protein into the plasma membrane of host erythrocytes |
| Q39106302 | Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania |
| Q47925251 | Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes |
| Q35516489 | Seroprevalence and specificity of human responses to the Plasmodium falciparum rhoptry protein Rhop-3 determined by using a C-terminal recombinant protein |
| Q35383761 | Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum |
| Q31063140 | Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge |
| Q33772752 | Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria |
| Q40373716 | Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of plasmodium falciparum |
| Q43144803 | Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant |
| Q36463298 | Stable Allele Frequency Distribution of the Plasmodium falciparum clag Genes Encoding Components of the High Molecular Weight Rhoptry Protein Complex |
| Q69566223 | Status of malaria vaccine research |
| Q44274141 | Structural diversity of Plasmodium falciparum gp200 is detected by T cells |
| Q43468469 | Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein |
| Q39086032 | Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. |
| Q28740432 | T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines |
| Q37483845 | The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody |
| Q34094870 | The apical organelles of malaria merozoites: host cell selection, invasion, host immunity and immune evasion. |
| Q47998652 | The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite |
| Q40910243 | The development of a multivalent DNA vaccine for malaria |
| Q47896181 | The high molecular mass rhoptry protein, RhopH1, is encoded by members of the clag multigene family in Plasmodium falciparum and Plasmodium yoelii |
| Q36551368 | Transmission blocking immunity may provide clues that antimalarial immunity is largely T-independent |
| Q38533026 | Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum |
| Q58129727 | Utilization of Nucleotide Probes in PCR‐ELISA Procedure for the Quantitative Determination ofPlasmodium FalciparumDNA in Malaria |
| Q36117148 | Vaccination against malaria |
| Q34003578 | Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys |
| Q36933780 | Vaccines against malaria - an update |
| Q36636738 | Where Are We in the Quest for Vaccines for Malaria? |
| Q45875096 | ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum |
Search more.